Blog calls on presidential candidates to discuss global health R&D

Noting "Mitt Romney will become the official nominee for the Republican Party at its convention in Florida" this week, Kim Lufkin, communications officer for the Global Health Technologies Coalition, writes in this post in the coalition's "Breakthroughs" blog, "Science and research will likely not appear on the agenda, as Romney, expected Vice Presidential candidate Paul Ryan, and others will instead focus on topics like reducing federal spending." She continues, "It's unfortunate that research will not be a part of the conversation, as new predictions coming out this week indicate that if Romney and Ryan win the election in November, changes could be coming for health research and efforts to develop much-needed new tools for global health." She concludes, "It's important that the candidates -- from Obama and Vice President Biden to Romney and Ryan -- start talking about these issues head-on," and "no matter which party takes the White House in November, support for global health [research and development (R&D)] must continue" (8/24).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
GluFormer outperforms existing AI models in predicting blood sugar levels